AI Agentic Workflow for Automated Drafting of Prescribing Information (PI) and Labeling

The manual drafting of Prescribing Information (PI) and Summary of Product Characteristics (SmPC) is a critical bottleneck, consuming weeks of highly skilled medical and regulatory writer time. A custom agentic workflow automates the initial draft by orchestrating specialized agents to retrieve structured data from clinical databases (e.g., SAS datasets, CDISC standards), interpret statistical outputs, and apply jurisdiction-specific regulatory phrasing templates from a managed library. This reduces the drafting phase from weeks to days, directly compressing submission timelines and freeing experts for high-value scientific review and strategy.

Implementation requires tight integration with clinical data warehouses (e.g., Medidata Rave), regulatory information management systems (Veeva RIM), and document management platforms (Veeva Vault). The orchestration layer, built with frameworks like LangGraph, manages state, handles exceptions, and enforces a human-in-the-loop review process through the structured Medical, Legal, Regulatory (MLR) workflow. Controls include versioning, audit trails, and confidence scoring on extracted data to flag sections requiring expert validation before the draft proceeds to formal review gates.

This workflow automates the high-effort, iterative drafting of Prescribing Information (PI) and Summary of Product Characteristics (SmPC). It directly targets the bottleneck where medical writers manually extract key efficacy and safety results from hundreds of pages of clinical study reports and apply complex regulatory phrasing conventions. The operational upside is a 60-80% reduction in initial drafting time, accelerating the critical path to submission while ensuring foundational consistency with source data and regulatory guidelines. Savings come from eliminating repetitive data lookup, copy-paste, and initial formatting labor.

Implementation involves deploying the orchestrator on a platform like LangGraph or CrewAI, with agents integrated via APIs to clinical data warehouses (e.g., Medidata Rave) and document management systems (e.g., Veeva Vault). The Data Extraction Agent uses RAG over CSR sections to pull specific efficacy endpoints and adverse event rates. The Template Application Agent applies approved regulatory language from a controlled library, ensuring consistency. The draft is then pushed into the existing Medical/Legal/Regulatory (MLR) review workflow in systems like Veeva PromoMats, preserving all required human oversight gates, comment logging, and version control.

Phase 1 establishes the core data pipeline, connecting agents to clinical data warehouses (e.g., Medidata Rave) and document repositories (Veeva Vault). This initial build focuses on extracting key efficacy and safety endpoints from structured study reports and applying foundational regulatory phrasing templates. The goal is to produce a draft PI skeleton with 80% accuracy, routed for human review via the existing MLR system, validating the data integration and basic orchestration logic before scaling complexity.

Phase 2 augments the system with multi-document RAG over unstructured sources (CSRs, protocols) and implements cross-referencing logic to ensure consistency between the draft PI and source data. Phase 3 finalizes production controls, adding validation for CDISC/SDTM alignment, exception routing for ambiguous data, and comprehensive audit trails. This staged approach de-risks adoption, delivers incremental ROI by automating the most repetitive drafting tasks first, and ensures the final system integrates seamlessly with submission planning and quality oversight.

Deploying an automated PI drafting workflow requires a governance architecture that embeds human oversight while maximizing throughput. The system must integrate with your MLR review platform (e.g., Veeva Vault PromoMats) and clinical data warehouses. Key controls include configurable approval gates for medical and regulatory review, version locking, and a full audit trail of all agent actions and data sources used. This ensures the draft remains an assistive tool, with final accountability resting with qualified personnel, preserving regulatory defensibility.

A phased rollout mitigates risk. Phase 1 pilots the agents on a single, closed study to validate output quality and tune extraction logic against your CSR templates. Phase 2 expands to a therapeutic area, integrating with the MLR system and establishing performance baselines for draft acceptance rates. Phase 3 scales to the portfolio, with continuous monitoring for template drift and regulatory guidance updates. This approach delivers incremental time savings—potentially cutting initial drafting from weeks to hours—while building organizational trust in the automated workflow.

Automating the drafting of Prescribing Information (PI) and labeling eliminates a major bottleneck in regulatory submissions, where medical writers manually extract efficacy and safety results from hundreds of clinical study pages. A custom workflow uses specialized agents to query structured data warehouses (e.g., clinical databases, CDISC SDTM/ADaM) and unstructured clinical summaries, applying pre-approved regulatory phrasing templates from systems like Veeva Vault PromoMats. This reduces initial drafting time from weeks to hours, ensures consistency with source data, and creates a structured draft ready for the formal Medical, Legal, Regulatory (MLR) review cycle.

Implementation requires orchestrating data extraction, template application, and human review within existing quality systems. The architecture, built on frameworks like LangGraph, integrates with clinical data warehouses and content management systems. Drafts are routed through a configured MLR workflow with electronic signatures, while a full audit trail logs all agent actions and data sources for regulatory inspection. This creates a repeatable, scalable operating model that cuts labeling cycle time and reduces administrative burden by over 60%.